13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
pmid:
Malone C et al. Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro. 1999 Clin. Cancer Res. pmid:10037192
Atanackovic G and Koren G Young women taking isotretinoin still conceive. Role of physicians in preventing disaster. 1999 Can Fam Physician pmid:10065298
Ebrahim O and Bredenhann M Roche responds to 'new warnings on the use of isotretinoin (Roaccutane)'. 1999 S. Afr. Med. J. pmid:10070397
Presbury D Roaccutane--a dermatologist's perspective. 1999 S. Afr. Med. J. pmid:10070398
Orris AS et al. Isotretinoin alters morphology, polarity, and motility of neural crest cells in culture. 1999 Jan-Feb Reprod. Toxicol. pmid:10080299
Graham BS and Barrett TL Mucosal denudation of the lips from isotretinoin therapy. 1999 Arch Dermatol pmid:10086464
Chichareon V et al. Fibrodysplasia ossificans progressiva and associated osteochondroma of the coronoid process in a child. 1999 Plast. Reconstr. Surg. pmid:10088512
Tosi P et al. In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells. 1999 Eur. J. Haematol. pmid:10089890
Chaspoux C et al. [Acne in the male resistant to isotretinoin and responsibility of androgens: 9 cases, therapeutic implications]. 1999 Ann Dermatol Venereol pmid:10095884
Degar BA et al. 13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma. 1999 Med. Pediatr. Oncol. pmid:10102029
Simpson N Effect of isotretinoin on the quality of life of patients with acne. 1994 Pharmacoeconomics pmid:10147436
Enzinger PC et al. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma. 1999 Cancer pmid:10189124
Padberg J et al. Drug interaction of isotretinoin and protease inhibitors: support for the cellular retinoic acid-binding protein-1 theory of lipodystrophy? 1999 AIDS pmid:10202838
Ng PP and Goh CL Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients. 1999 Int. J. Dermatol. pmid:10208621
Ginarte M et al. Keloid formation induced by isotretinoin therapy. 1999 Int. J. Dermatol. pmid:10208624
Hatcher L Who's heard of the Pregnancy Prevention Program? 1999 Can Fam Physician pmid:10216779
Mengesha YM and Hansen RC Toddler-age nodulocystic acne. 1999 J. Pediatr. pmid:10228304
Kellett SC and Gawkrodger DJ The psychological and emotional impact of acne and the effect of treatment with isotretinoin. 1999 Br. J. Dermatol. pmid:10233222
Neubert U et al. Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients. 1999 Int. J. Dermatol. pmid:10321942
Schulpis KH et al. The effect of isotretinoin on biotinidase activity. 1999 Jan-Apr Skin Pharmacol. Appl. Skin Physiol. pmid:10325581
Saxe N Warnings on the use of isotretinoin. 1999 S. Afr. Med. J. pmid:10341806
Schmuth M et al. Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous? 1999 Br. J. Dermatol. pmid:10354041
Makori N et al. 13-cis-Retinoic acid alters neural crest cells expressing Krox-20 and Pax-2 in macaque embryos. 1999 Anat. Rec. pmid:10359515
von Marschall Z et al. Induction of matrix metalloprotease-1 gene expression by retinoic acid in the human pancreatic tumour cell line Dan-G. 1999 Br. J. Cancer pmid:10362099
Kröger MJ et al. Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapy--a pilot study. 1999 Mar-Apr Anticancer Res. pmid:10365144
Gravis G et al. Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma. 1999 Anticancer Drugs pmid:10378671
D'Arcy PF [Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom]. 1999 Mar-Apr J Pharm Belg pmid:10380410
Lehucher-Ceyrac D et al. Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients. 1999 Dermatology (Basel) pmid:10393453
Choquet-Kastylevsky G et al. [Recurrent subcutaneous edema induced by isotretinoin]. 1999 Mar-Apr Therapie pmid:10394267
[Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products]. 1999 Ann Dermatol Venereol pmid:10394434
[Systemic treatment of acne: recommendations. The French Agency of Sanitary Safety of Health Products]. 1999 Ann Dermatol Venereol pmid:10394435
Cott AD and Wisner KL Isotretinoin treatment of a woman with bipolar disorder. 1999 J Clin Psychiatry pmid:10401921
Atanackovic G and Koren G Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program. 1999 CMAJ pmid:10410634
Shear NH Oral isotretinoin: prescribers beware. 1999 CMAJ pmid:10410636
Rigobello MP et al. Mitochondrial permeability transition and release of cytochrome c induced by retinoic acids. 1999 Biochem. Pharmacol. pmid:10413304
Kirby B et al. Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia. 1999 Br. J. Dermatol. pmid:10417840
Le XF et al. Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway. 1999 J. Biol. Chem. pmid:10419474
Salasche SJ and Lebwohl M Clinical pearl: vitamin E (alpha-tocopherol), 800 IU daily, may reduce retinoid toxicity. 1999 J. Am. Acad. Dermatol. pmid:10426898
Berg WJ et al. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a. 1999 Clin. Cancer Res. pmid:10430067
Datta PK and Lianos EA Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. 1999 Kidney Int. pmid:10432387
Xu XC et al. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. 1999 J. Natl. Cancer Inst. pmid:10433621
Källén B Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin. 1999 Teratology pmid:10440771
Nicke B et al. Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells. 1999 Biochem. Biophys. Res. Commun. pmid:10441468
Neele DM et al. No short-term effect of oral isotretinoin (13-cis retinoic acid) on lipoprotein(a) and HDL subclasses LP-A-I and LP-A-I:A-II in healthy volunteers. 1999 J. Intern. Med. pmid:10447235
Beenken SW et al. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid. 1999 Head Neck pmid:10449674
Honein MA and Paulozzi LJ Cost-effectiveness of oral isotretinoin. 1999 Dermatology (Basel) pmid:10449945
Lehucher Ceyrac D Acute arthritis after isotretinoin. 1999 Dermatology (Basel) pmid:10449946
Leachman SA et al. Bone densities in patients receiving isotretinoin for cystic acne. 1999 Arch Dermatol pmid:10456346
Chu A and Cunliffe WJ The inter-relationship between isotretinoin/acne and depression. 1999 J Eur Acad Dermatol Venereol pmid:10461651
Saade M et al. Clinical remission of xeroderma pigmentosum-associated squamous cell carcinoma with isotretinoin and chemotherapy: case report. 1999 J Chemother pmid:10465136
Libow LF and Friar DA Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. 1999 Cutis pmid:10467498
Rosen T and Unkefer RP Treatment of pyoderma faciale with isotretinoin in a patient with ulcerative colitis. 1999 Cutis pmid:10467503
Seukeran DC and Cunliffe WJ The treatment of acne fulminans: a review of 25 cases. 1999 Br. J. Dermatol. pmid:10468806
Wessels F et al. The cost-effectiveness of isotretinoin in the treatment of acne. Part 1. A meta-analysis of effectiveness literature. 1999 S. Afr. Med. J. pmid:10470317
Wessels F et al. The cost-effectiveness of isotretinoin in the treatment of acne. Part 2. A chronic medication plan profiling study. 1999 S. Afr. Med. J. pmid:10470318
Wessels F et al. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model. 1999 S. Afr. Med. J. pmid:10470319
Somos S et al. Cancer protection in xeroderma pigmentosum variant (XP-V). 1999 May-Jun Anticancer Res. pmid:10472330
Puduvalli VK et al. Fenretinide activates caspases and induces apoptosis in gliomas. 1999 Clin. Cancer Res. pmid:10473110
Placzek M et al. Acne fulminans in late-onset congenital adrenal hyperplasia. 1999 Lancet pmid:10475188
Brandt JR and Mick TJ Extraspinal enthesopathy caused by isotretinoin therapy. 1999 Jul-Aug J Manipulative Physiol Ther pmid:10478775
White GM Acne therapy. 1999 Dis Mon pmid:10481765
Prokop LD Isotretinoin: possible component cause of inflammatory bowel disease. 1999 Am. J. Gastroenterol. pmid:10484032
Jemec GB Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. 1999 J. Am. Acad. Dermatol. pmid:10495491
López-Vílchez MA et al. [Acne fulminans after the treatment with isotretinoin]. 1999 An. Esp. Pediatr. pmid:10495512
DeRose JJ et al. Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. 1999 Cardiovasc Surg pmid:10519672
Matthay KK et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. 1999 N. Engl. J. Med. pmid:10519894
Papadimitrakopoulou VA et al. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. 1999 Arch. Otolaryngol. Head Neck Surg. pmid:10522499
Ayoub J et al. Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer. 1999 J. Clin. Oncol. pmid:10550153
Koerber C et al. Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid. 1999 Clin Nucl Med pmid:10551465
Steele RG et al. Premature epiphyseal closure secondary to single-course vitamin A therapy. 1999 Aust N Z J Surg pmid:10553976
Patel GK et al. Localised facial swelling associated with isotretinoin. 1999 Dermatology (Basel) pmid:10559604
DiPaola RS et al. Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies. 1999 J. Clin. Oncol. pmid:10561278
Leenutaphong V et al. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. 1999 J Med Assoc Thai pmid:10561942
McKenna KE et al. Treatment of unilateral Darier's disease with topical isotretinoin. 1999 Clin. Exp. Dermatol. pmid:10564339
Schulpis K et al. Psychological and sympatho-adrenal status in patients with cystic acne. 1999 J Eur Acad Dermatol Venereol pmid:10565626
Csaba G et al. The effect of perinatal hormonal imprinting with 13-cis-retinoic acid (isotretinoin) on the thymic glucocorticoid receptors of female and testosterone level of male adult rats. 1999 Horm. Metab. Res. pmid:10569251
Welsh BM et al. Night blindness precipitated by isotretinoin in the setting of hypovitaminosis A. 1999 Australas. J. Dermatol. pmid:10570558
Toros P et al. Bilateral nipple hyperkeratosis treated successfully with topical isotretinoin. 1999 Australas. J. Dermatol. pmid:10570562
Hoffmann W et al. Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha. 1999 Int. J. Radiat. Oncol. Biol. Phys. pmid:10571207
Stitik TP et al. Greater trochanter enthesopathy: an example of "short course retinoid enthesopathy": a case report. 1999 Nov-Dec Am J Phys Med Rehabil pmid:10574173
Azurdia RM and Sharpe GR Isotretinoin treatment for acne vulgaris and its cutaneous and ocular side-effects. 1999 Br. J. Dermatol. pmid:10583197
Bläse M et al. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity. 1999 Strahlenther Onkol pmid:10584127
Simoni D et al. Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid. 1999 J. Med. Chem. pmid:10585206
Weisshaar E et al. Familial nevoid sebaceous gland hyperplasia affecting three generations of a family. 1999 Eur J Dermatol pmid:10586129
Glass D et al. A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. 1999 Dermatology (Basel) pmid:10592405
Ishijima K and Sando I Multiple temporal bone anomalies in isotretinoin syndrome: a temporal bone histopathologic case report. 1999 Arch. Otolaryngol. Head Neck Surg. pmid:10604421
Recchia F et al. Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study. 1999 Jul-Aug Clin Ter pmid:10605163
[Oral treatment of acne. Agence Française de Securité Sanitaire des Produits de Santé]. 1999 Presse Med pmid:10605476
Belaich S [Apropos of recommendations concerning oral treatment of acne. An interview with the president S. Belaich. Interview by Hélne Allouch]. 1999 Presse Med pmid:10605477
Gamble MV et al. Substrate specificities and 13-cis-retinoic acid inhibition of human, mouse and bovine cis-retinol dehydrogenases. 2000 Biochim. Biophys. Acta pmid:10606761
Downs AM et al. Isotretinoin therapy for antibiotic-refractory acne in Apert's syndrome. 1999 Clin. Exp. Dermatol. pmid:10606949
Maddin S et al. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. 2000 J. Am. Acad. Dermatol. pmid:10607320
Simpson-Dent S et al. HIV associated eosinophilic folliculitis--differential diagnosis and management. 1999 Sex Transm Infect pmid:10616350
Shin DM et al. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. 2000 J. Natl. Cancer Inst. pmid:10620636
Piattelli A et al. bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study. 1999 Oral Oncol. pmid:10621853
Thiboutot DM Acne and rosacea. New and emerging therapies. 2000 Dermatol Clin pmid:10626112
Tetè S et al. The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin. 1999 Minerva Stomatol pmid:10638174
Georgala S et al. L-carnitine supplementation in patients with cystic acne on isotretinoin therapy. 1999 J Eur Acad Dermatol Venereol pmid:10642057
White GM Acne therapy. 1999 Adv Dermatol pmid:10643494